Submitted by Anonymous (not verified) on 18 May 2026 - 14:42
Human medicines European public assessment report (EPAR): Usrenty, ustekinumab, Date of authorisation: 17/09/2025, Revision: 2, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Usrenty, ustekinumab, Date of authorisation: 17/09/2025, Revision: 2, Status: Authorised